PRMSE: Screening for All Announces Guillaume Calmon as Chief Technology Officer
Naarden, the Netherlands, September 26, 2024
PRMSE:, a leader in AI-driven image analysis for lung cancer screening, today announced the appointment of Guillaume Calmon, as Chief Technology Officer (CTO). Guillaume brings more than 25 years of experience in Health Tech R&D and leadership to the role.
Guillaume comes to PRSME: with a wealth of experience in several areas. He has deep knowledge of CT technology and image processing. In addition, he has strong experience in AI systems and how they need to be engineered successfully. Having fulfilled multiple responsibilities on both the engineering and clinical side and led young health tech companies in and outside the medical and radiological fields, Guillaume understands the large OEM manufacturers in radiology, and the entrepreneurial world. Guillaume is not only passionate about solving patients’ ever-changing needs with creative technical solutions, but also fostering a culture of collaboration and continuous learning. Prior to joining PRSME:, Guillaume has held key roles in leading Health Tech companies including GE Healthcare and Becton Dickinson.
“PRSME:’s solutions address the radiologist shortage, offering scalable, early detection through low-dose CT scans. We're excited to welcome Guillaume as our new CTO at this pivotal moment for AI in healthcare technology adoption. By accelerating innovation in AI-driven image analysis for lung cancer screening, PRSME: aims to save lives by making early screening accessible to all,” said Pieter van der Poel, Founder and CEO at PRSME:.
“PRSME:’s cutting-edge technology and unwavering commitment to leveraging AI for healthcare imaging create a powerful foundation for innovation. I'm impressed by the team's vision to develop solutions to enable lung cancer screening for all. I'm eager to apply my expertise and lead the team in enhancing PRSME:’s AI capabilities, ultimately helping radiologists save time in interpreting images and improving outcomes for patients around the world,” said Guillaume Calmon, CTO at PRSME:. Guillaume will be responsible for defining PRMSE:’s technology roadmap in alignment with business objectives, facilitating strategic collaboration, and supporting the company in advancing the frontier of AI in the healthcare industry.
LinkedIn: https://www.linkedin.com/in/gcalmon/
About PRMSE:
PRMSE: Screening for All is a healthcare technology startup company. PRMSE: provides AI-tools that enable large-scale patient screening. PRMSE:’s solutions create a rule-out system for screening high-risk lung cancer patients, leaving the radiologist to analyze and follow up on the potentially positive patient cases. The Company is based in the Netherlands.
https://www.prmse-screening.com/news-media/promise-the-beginning
For more information: please contact Manuela van der Poel, COO at
